Archive

Almonds and their Impact on mental health and the gut-brain axis in adults with symptoms of anxiety and depression: a 12-week randomized controlled trial.

Sartori, L., N. Argomaniz, D.N. Farsi, B. Bajka, D. Chrysostomou, J.R. Marchesi, J. Chilcot, K. Whelan, E. Dimidi, 2026. Almonds and their Impact on mental health and the gut-brain axis in adults with symptoms of anxiety and depression: a 12-week randomized controlled trial. J Nutr. 156(9):101732. doi: 10.1016/j.tjnut.2026.101732.

Background: Almonds contain dietary fiber, micronutrients, and phytochemicals that have been implicated in the regulation of the gut-brain axis and mental health. Objectives: The aim of this study was to investigate the effect of whole almonds, compared with an isocaloric snack, on mental health and the gut-brain axis, in adults with symptoms of anxiety and depression. Methods: Adults with mild-to-moderate symptoms of anxiety and depression participated in a randomized controlled trial, receiving almonds (56 g/d) or isocaloric control for 12 wk. The primary outcome was symptoms of anxiety and depression (Patient Health Questionnaire Anxiety and Depression Scale) at week 12. Secondary mental health outcomes were measured at weeks 0, 6, and 12. Gut microbiota composition (16S rRNA gene sequencing), short-chain fatty acids (SCFAs; gas chromatography), stool output (frequency and consistency), and gut symptoms (7-d diary) were measured at weeks 0 and 12. Results: Eighty-four participants were recruited (mean age 25 y, 75% female). There was no significant difference in anxiety and depression scores between the almond (mean ± SD, 11.6 ± 5.3) and control group (12.5 ± 5.3; P = 0.945). Functional impairment was borderline significantly improved in the almond group (9.6 ± 7.0) compared with control (12.2 ± 8.7, P = 0.055) in the intention-to-treat analysis and was significant in the per-protocol analysis (almond 9.0 ± 6.4 compared with control 12.5 ± 9.6; P = 0.015). Almonds did not alter the gut microbiota composition or SCFA concentrations. Almonds significantly reduced the frequency of hard stools compared with control (median [interquartile range]: 0.0 [0.1] compared with 0.1 [0.4] stools/d, P = 0.002), with no impact on gut symptoms. Conclusions: Almond consumption for 12 wk has limited impact on anxiety and depression, although it may impact functional impairment in adults with mild-to-moderate anxiety and depression. Further research is needed in populations with severe depression and anxiety. This trial was registered at clinicaltrials.gov as NCT06087471.

Urolithins from walnuts are associated with cognitive performance: ancillary results from the Walnuts and Healthy Aging (WAHA) randomized trial.

Galkina, P., I. Domínguez-López, M. Cofán, C. Pozzoli, O. Jáuregui, C. Abarca-Rivas, M. Corrado, A. Vallverdú-Queralt, M. Serra-Mir, G. Chiva-Blanch, S. Rajaram, J. Sabaté, A. Sala-Vila, E. Ros, R.M. Lamuela-Raventós, 2026. Urolithins from walnuts are associated with cognitive performance: ancillary results from the Walnuts and Healthy Aging (WAHA) randomized trial. Food Science and Human Wellness. doi: https://doi.org/10.26599/FSHW.2026.9251028.

Urolithins, microbiota-derived metabolites of ellagitannins, phenolic compounds abundant in walnuts, possess anti-inflammatory and antioxidant properties that might mitigate neuronal damage. However, clinical data supporting their effects on cognition are limited. In participants in the Walnuts and Healthy Aging (WAHA) trial, we determined urinary urolithin concentrations and examined their association with cognitive performance. The WAHA study was a parallel-group, 2-center (Barcelona, Spain; Loma Linda, California), randomized controlled trial. Cognitively healthy individuals followed a 2-year walnut-rich diet (15% daily energy) or a control diet excluding walnuts. Baseline and 2-year determinations included urinary urolithins by liquid chromatography-mass spectrometry and a comprehensive neuropsychological battery. The primary outcome was the association between changes in a global cognition composite score and urinary urolithins as the exposure, assessed by multivariable-adjusted regression. Secondary outcomes included associations of urolithins with domain-specific changes in memory, language, perception, and frontal function. A total of 612 participants (66% women, mean age 69 y) were included in analyses. Urolithin A, urolithin C and their glucuronide forms were objective biomarkers of walnut consumption (area under the curve at receiver operator characteristic analysis, 0.83; 95% CI, 0.80-0.86, 0.78; 95% CI, 0.74-0.82, 0.81; 95% CI, 0.77-0.84, and 0.80; 95% CI, 0.76-0.83, respectively). In the WAHA cohort following the walnut diet, changes in urolithin A glucuronide (β = 0.014 [95% CI, 0.003-0.025] per 1-SD) and urolithin C (β = 0.017 [95% CI, 0.001-0.033] per 1-SD) were associated with concurrent changes of the global cognition score. Urinary urolithins, particularly UroA, UroC and their glucuronides, are reliable biomarkers of walnut consumption. Changes in urolithin levels after 2 years of daily walnut consumption disclosed a direct association with cognitive performance in cognitively healthy older individuals. These findings provide clinical evidence linking dietary (poly)phenols and cognitive health.

Microbiota-derived urolithins and cortical thickness in cognitively healthy older adults: a longitudinal MRI analysis of the WAHA trial.

Galkina, P., I. Domínguez-López, M. Cofán, C. Pozzoli, A. Vallverdú-Queralt, M. Serra-Mir, G. Chiva-Blanch, S. Rajaram, J. Sabaté, A. Sala-Vila, E. Ros, R.M. Lamuela-Raventós, 2026. Microbiota-derived urolithins and cortical thickness in cognitively healthy older adults: a longitudinal MRI analysis of the WAHA trial. Food & Function. doi: https://doi.org/10.1039/D6FO02116F.

Background & aims: Walnuts are nutrient-dense foods rich in bioactive compounds that may support mental health. However, evidence linking walnut consumption to mood regulation and to changes in urinary metabolites potentially associated with these effects in humans remains limited. This randomized crossover trial (RCT) aimed to evaluate the effects of an 8-week walnut (Juglans regia) intervention on mood states in young adults and to explore the potential mechanistic links through urinary serotonin metabolite (5-hydroxyindoleacetic acid, 5-HIAA), cortisol, and urolithins. Methods: In this 18-week open-label RCT, 31 healthy young adults (mean age 24.0 ± 4.2 years; 90.3% female) consumed 40 g per day of walnuts for 8 weeks (intervention) and followed a nut-free control period of equal length, separated by a 2-week washout. Mood states, perceived stress, well-being, and trait food cravings were assessed using validated questionnaires. Urinary concentrations of 5-HIAA and cortisol were quantified via ELISA and normalized to creatinine. Walnut-derived urolithins were determined in urine samples as biomarkers of intake by HPLC-QTOF-MS. Linear mixed-effects models were used to test differences in outcome variables between intervention and control conditions, and repeated-measures correlations were performed to assess within-individual associations between the outcome variables. Results: Compared to the control condition, the 8-week walnut intervention significantly reduced total mood disturbance scores (−4.85 points, p = 0.030). In addition, the walnut intervention significantly increased urinary 5-HIAA levels, with no changes in urinary cortisol. Increases in urinary 5-HIAA were significantly associated with reductions in fatigue (r = –0.392, p = 0.031) and total mood disturbance (r = –0.362, p = 0.049). Urinary levels of urolithins significantly increased during the intervention and were strongly correlated with concurrent changes in urinary 5-HIAA (r = 0.537 and r = 0.634, respectively). Conclusions: Daily walnut consumption improved total mood disturbance scores in young adults. These findings were accompanied by increased urinary 5-HIAA and urolithin levels. The concurrent changes in these urinary metabolites may reflect dietary, microbial, or peripheral metabolic responses to walnut consumption; however, mechanistic pathways warrant further investigation. These findings highlight the relevance of whole-food strategies in nutritional approaches to mental health.

Walnut consumption improves mood and is associated with increased urinary excretion of 5-hydroxyindoleacetic acid and urolithins in a randomized crossover trial.

Zerón-Rugerio, M.F., I. Parilli-Moser, A. Gonzalez-Rodriguez, M. Urpi-Sarda, M. Diez-Hernández, A. Ibarra-Picón, B. Barrau-Martinez, F.J. Pérez-Cano, T. Cambras, M. Izquierdo-Pulido, 2026. Walnut consumption improves mood and is associated with increased urinary excretion of 5-hydroxyindoleacetic acid and urolithins in a randomized crossover trial. Food & Function. doi: https://doi.org/10.1039/D6FO00807K

Background & aims: Walnuts are nutrient-dense foods rich in bioactive compounds that may support mental health. However, evidence linking walnut consumption to mood regulation and to changes in urinary metabolites potentially associated with these effects in humans remains limited. This randomized crossover trial (RCT) aimed to evaluate the effects of an 8-week walnut (Juglans regia) intervention on mood states in young adults and to explore the potential mechanistic links through urinary serotonin metabolite (5-hydroxyindoleacetic acid, 5-HIAA), cortisol, and urolithins. Methods: In this 18-week open-label RCT, 31 healthy young adults (mean age 24.0 ± 4.2 years; 90.3% female) consumed 40 g per day of walnuts for 8 weeks (intervention) and followed a nut-free control period of equal length, separated by a 2-week washout. Mood states, perceived stress, well-being, and trait food cravings were assessed using validated questionnaires. Urinary concentrations of 5-HIAA and cortisol were quantified via ELISA and normalized to creatinine. Walnut-derived urolithins were determined in urine samples as biomarkers of intake by HPLC-QTOF-MS. Linear mixed-effects models were used to test differences in outcome variables between intervention and control conditions, and repeated-measures correlations were performed to assess within-individual associations between the outcome variables. Results: Compared to the control condition, the 8-week walnut intervention significantly reduced total mood disturbance scores (-4.85 points, p = 0.030). In addition, the walnut intervention significantly increased urinary 5-HIAA levels, with no changes in urinary cortisol. Increases in urinary 5-HIAA were significantly associated with reductions in fatigue (r = -0.392, p = 0.031) and total mood disturbance (r = -0.362, p = 0.049). Urinary levels of urolithins significantly increased during the intervention and were strongly correlated with concurrent changes in urinary 5-HIAA (r = 0.537 and r = 0.634, respectively). Conclusions: Daily walnut consumption improved total mood disturbance scores in young adults. These findings were accompanied by increased urinary 5-HIAA and urolithin levels. The concurrent changes in these urinary metabolites may reflect dietary, microbial, or peripheral metabolic responses to walnut consumption; however, mechanistic pathways warrant further investigation. These findings highlight the relevance of whole-food strategies in nutritional approaches to mental health.